These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9653605)

  • 1. Postmenopausal estrogens and risk of myocardial infarction in diabetic women.
    Kaplan RC; Heckbert SR; Weiss NS; Wahl PW; Smith NL; Newton KM; Psaty BM
    Diabetes Care; 1998 Jul; 21(7):1117-21. PubMed ID: 9653605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women.
    Heckbert SR; Weiss NS; Koepsell TD; Lemaitre RN; Smith NL; Siscovick DS; Lin D; Psaty BM
    Arch Intern Med; 1997 Jun; 157(12):1330-6. PubMed ID: 9201007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women.
    Psaty BM; Heckbert SR; Atkins D; Lemaitre R; Koepsell TD; Wahl PW; Siscovick DS; Wagner EH
    Arch Intern Med; 1994 Jun; 154(12):1333-9. PubMed ID: 8002685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current use of unopposed estrogen and estrogen plus progestin and the risk of acute myocardial infarction among women with diabetes: the Northern California Kaiser Permanente Diabetes Registry, 1995-1998.
    Ferrara A; Quesenberry CP; Karter AJ; Njoroge CW; Jacobson AS; Selby JV;
    Circulation; 2003 Jan; 107(1):43-8. PubMed ID: 12515741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women.
    Psaty BM; Smith NL; Lemaitre RN; Vos HL; Heckbert SR; LaCroix AZ; Rosendaal FR
    JAMA; 2001 Feb; 285(7):906-13. PubMed ID: 11180734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women.
    Sidney S; Petitti DB; Quesenberry CP
    Ann Intern Med; 1997 Oct; 127(7):501-8. PubMed ID: 9313017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esterified estrogen and conjugated equine estrogen and the risk of incident myocardial infarction and stroke.
    Lemaitre RN; Weiss NS; Smith NL; Psaty BM; Lumley T; Larson EB; Heckbert SR
    Arch Intern Med; 2006 Feb; 166(4):399-404. PubMed ID: 16505258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of replacement estrogens and the risk of myocardial infarction.
    Hernandez Avila M; Walker AM; Jick H
    Epidemiology; 1990 Mar; 1(2):128-33. PubMed ID: 2073499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
    Carr BR; Ory H
    Contraception; 1997 May; 55(5):267-72. PubMed ID: 9220222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. A prospective cohort study.
    Troisi RJ; Speizer FE; Willett WC; Trichopoulos D; Rosner B
    Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1183-8. PubMed ID: 7551368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogens.
    Smith NL; Blondon M; Wiggins KL; Harrington LB; van Hylckama Vlieg A; Floyd JS; Hwang M; Bis JC; McKnight B; Rice KM; Lumley T; Rosendaal FR; Heckbert SR; Psaty BM
    JAMA Intern Med; 2014 Jan; 174(1):25-31. PubMed ID: 24081194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemic stroke and use of estrogen and estrogen/progestogen as hormone replacement therapy.
    Petitti DB; Sidney S; Quesenberry CP; Bernstein A
    Stroke; 1998 Jan; 29(1):23-8. PubMed ID: 9445323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
    N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.
    Smith NL; Heckbert SR; Lemaitre RN; Reiner AP; Lumley T; Weiss NS; Larson EB; Rosendaal FR; Psaty BM
    JAMA; 2004 Oct; 292(13):1581-7. PubMed ID: 15467060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up.
    Alexander KP; Newby LK; Hellkamp AS; Harrington RA; Peterson ED; Kopecky S; Langer A; O'Gara P; O'Connor CM; Daly RN; Califf RM; Khan S; Fuster V
    J Am Coll Cardiol; 2001 Jul; 38(1):1-7. PubMed ID: 11451256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population.
    Kerlikowske K; Miglioretti DL; Ballard-Barbash R; Weaver DL; Buist DS; Barlow WE; Cutter G; Geller BM; Yankaskas B; Taplin SH; Carney PA
    J Clin Oncol; 2003 Dec; 21(23):4314-21. PubMed ID: 14645420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
    Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of hormone therapy and incident gout: population-based case-control study.
    Bruderer SG; Bodmer M; Jick SS; Meier CR
    Menopause; 2015 Dec; 22(12):1335-42. PubMed ID: 25968834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial infarction risk and hormone replacement: differences between products.
    de Vries CS; Bromley SE; Farmer RD
    Maturitas; 2006 Feb; 53(3):343-50. PubMed ID: 16040209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type of postmenopausal hormone use and risk of breast cancer: 12-year follow-up from the Nurses' Health Study.
    Colditz GA; Stampfer MJ; Willett WC; Hunter DJ; Manson JE; Hennekens CH; Rosner BA; Speizer FE
    Cancer Causes Control; 1992 Sep; 3(5):433-9. PubMed ID: 1525324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.